Jiyeon Lee is an advisor in Lee & Ko’s Healthcare Practice Group. Ms. Lee has built a distinguished career in market access at several global pharmaceutical companies, with a focus on oncology, rare disease, and chronic disease therapies. Her work has included reimbursement listing, expansion of reimbursement criteria, and pricing negotiation strategies for pharmaceutical products. Ms. Lee is particularly experienced in navigating reimbursement pathways for high-cost biologics and therapies involving significant clinical or economic uncertainty. By applying value-based approaches that integrate clinical and economic evidence, she has successfully supported reimbursement listings and expanded reimbursement criteria for complex medical treatments. Ms. Lee’s technical capabilities span the healthcare policy and regulatory science lifecycle, including health economic evaluation modeling, real-world evidence generation, and policy-level decision support for regulatory and reimbursement decision-making.

Drawing on her extensive industry experience and technical expertise, she provides evidence-based strategic support to pharmaceutical and biotechnology companies, healthcare institutions, and research organizations on product listing and pricing strategies, alignment of clinical value with economic requirements, and the evolving regulatory landscape for patient access to innovative medicines.